Implementing an Antimicrobial Stewardship Program

- Introduction

Antimicrobial stewardship (AMS) is a systematic effort to optimize the use of antimicrobial medications (antibiotics, antifungals, antivirals, and antiparasitics) to improve patient outcomes, reduce the emergence of antimicrobial resistance (AMR), and minimize healthcare costs. In healthcare facilities, implementing a robust AMS program is crucial for safeguarding the effectiveness of these vital medications for current and future patients.  

The increasing threat of AMR poses a significant global public health challenge. Overuse and misuse of antimicrobials in healthcare contribute significantly to this crisis, leading to:  

●       Increased treatment failures: Infections become harder, and sometimes impossible, to treat.  

●       Prolonged hospital stays: Patients with resistant infections often require longer and more complex treatment.  

●       Increased morbidity and mortality: Resistant infections can lead to more severe illness and higher death rates.  

●       Higher healthcare costs: Treating resistant infections often involves more expensive and toxic medications.  

●       Spread of resistant organisms: Resistant bacteria can spread within healthcare facilities and into the community.  

●       Limited development of new antimicrobials: The pace of new antimicrobial development is slow, further exacerbating the problem.  

Key Principles of Antimicrobial Stewardship:

Effective AMS programs are built upon several core principles:

1.    Leadership Support: Strong commitment and active involvement from hospital leadership are essential for providing the necessary resources and authority for the program.  

2.    Multidisciplinary Team: Collaboration among infectious disease physicians, clinical pharmacists, microbiologists, infection preventionists, nurses, and other healthcare professionals is crucial for a comprehensive approach.  

3.    Drug Expertise: A clinical pharmacist with expertise in infectious diseases plays a vital role in optimizing antimicrobial prescribing and monitoring.  

4.    Evidence-Based Practices: Decisions regarding antimicrobial use should be guided by current clinical guidelines, local antibiograms (reports summarizing antimicrobial susceptibility patterns of local isolates), and patient-specific factors.  

5.    Monitoring and Surveillance: Regular collection and analysis of data on antimicrobial use and resistance patterns are essential for identifying areas for improvement and tracking the impact of interventions.

6.    Interventions to Improve Antimicrobial Use: Implementing targeted strategies to promote optimal prescribing, such as:

-   Prospective audit and feedback: Reviewing antimicrobial orders and providing feedback to prescribers.  

-   Pre-authorization: Requiring approval for the use of certain restricted antimicrobials.

-   Formulary restriction: Limiting the availability of specific antimicrobials.  

-   Clinical pathways and guidelines: Developing and implementing standardized treatment approaches for common infections.  

-   Antimicrobial "time-outs": Encouraging prescribers to reassess the ongoing need for antimicrobials after a defined period.

-   Dose optimization: Ensuring appropriate dosing based on patient factors (e.g., weight, renal function).  

-   De-escalation: Switching from broad-spectrum to narrow-spectrum antibiotics when the pathogen and its susceptibilities are known.  

7.    Education and Training: Providing ongoing education and training to all healthcare professionals on principles of antimicrobial stewardship and best practices for antimicrobial use.  

8.    Reporting and Feedback: Regularly communicating data on antimicrobial use and resistance to prescribers, hospital committees, and leadership to promote accountability and drive change.  

Implementing an AMS program is a step-wise process. Initial steps may include:

●       Conducting a baseline assessment: Evaluating current antimicrobial prescribing practices and identifying areas of concern.  

●       Establishing an AMS team: Assembling a multidisciplinary group to lead the initiative.

●       Developing an AMS policy: Outlining the program's goals, strategies, and responsibilities.  

●       Prioritizing initial interventions: Focusing on a few key areas with the greatest potential for impact.

●       Developing a system for monitoring antimicrobial use: Tracking which drugs are being used, for what indications, and for how long.